Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PLECANATIDE Cause Product use in unapproved indication? 51 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Product use in unapproved indication have been filed in association with PLECANATIDE (Trulance Immediate release). This represents 5.3% of all adverse event reports for PLECANATIDE.

51
Reports of Product use in unapproved indication with PLECANATIDE
5.3%
of all PLECANATIDE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product use in unapproved indication From PLECANATIDE?

Of the 51 reports.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PLECANATIDE. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does PLECANATIDE Cause?

Diarrhoea (298) Drug ineffective (100) Constipation (92) Abdominal distension (83) Nausea (72) Abdominal pain (71) Abdominal pain upper (70) Flatulence (58) Muscle spasms (49) Abdominal discomfort (47)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which PLECANATIDE Alternatives Have Lower Product use in unapproved indication Risk?

PLECANATIDE vs PLERIXAFOR PLECANATIDE vs PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE PLECANATIDE vs PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE PLECANATIDE vs PNEUMOCOCCAL VACCINE POLYVALENT PLECANATIDE vs PNEUMOCOCCAL VACCINE, POLYVALENT 23

Related Pages

PLECANATIDE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication PLECANATIDE Demographics